This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Tornier, N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry, the Company’s Chief Operating Officer, and Carmen Diersen, the Company’s Chief Financial Officer, will be presenting at the Wells Fargo Securities Research and Economics 2012 Healthcare Conference.
The Company’s presentation is scheduled for Tuesday, June 19, at 10:15 a.m. eastern time at the Intercontinental Hotel in Boston.
The presentation will be webcast live on the Investor Relations section of the Company's website at
www.tornier.com. For those who are not available to listen to the live webcast, a replay will be archived for one year.
Tornier is a global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The Company's broad offering of approximately 90 product lines includes joint replacement, trauma, sports medicine, and biologic products to treat the extremities, as well as joint replacement products for the hip and knee in certain international markets. Since its founding approximately 70 years ago, Tornier's "Specialists Serving Specialists" philosophy has fostered a tradition of innovation, intense focus on surgeon education, and commitment to advancement of orthopedic technology stemming from its close collaboration with orthopedic surgeons and thought leaders throughout the world. For more information regarding Tornier, visit